Global Pharmaceutical and Biotechnology Outlo
Published Date: January 2014 Price: Single User: US$2500
No. of Pages: 113 Corporate User: US$7500
New Market Research Report on “ Global Pharmaceutical and Biotechnology Outlook 2014 :Rising Stars � added to ReportsnReports.com
Innovations have contributed to the availability of a range of new treatments for diseases resulting in improvement in the length and quality of life and reduced disease burden for individuals and society. However, the need for innovative therapies for unmet needs /challenging diseases continues to grow, accelerating the pace of drug development directly or through partnership/ inlicensing. We expect innovation and improved drugs therapies through novel target discovery
Global Pharmaceutical and Biotechnology Outlook 201 and technology platforms to continue to flow from the backyards of small research focused companies (Rising Stars, RS – non-profitable biotech companies) in coming years. Approval of new drugs, successful launches, maturing pipeline sustained the growth trajectory of biotech companies resulting in successful IPOs. We expect the optimism to percolate further into companies with novel technology platforms and targets. For more details on the trend in drug approvals, upcoming milestones and M&A in Browse more research reports on Pharmaceuticals @ http://www.reportsnreports.com/market-research/pharmaceuticals/
Global Pharmaceutical and Biotechnology Outlook 201 coming years please see Global Pharmaceutical and Biotechnology Outlook 2014 :Rising Stars Table of Contents Macro Analysis • Drug Approval in 2013 • PERFORMANCE OF IPOS: 2013 • DRUG LAUNCHES: 2014/15 • Unmet Need of Innovators - Launched and Pipeline Unpartnered Compounds
Buy a copy of this report @ http://www.reportsnreports.com/purchase.aspx?name=274681 .
Global Pharmaceutical and Biotechnology Outlook 201 • Competition can reduce the life span of innovative patented drugs- Competitive landscape of PI3K, Jak and BTK inhibitors in clinical development • Resisting resistance – Global threat and Action taken • Oral vs. Injectables – Oral drugs for MS, RA and Psoriasis • Targeting Unmet Need on Hematological MalignanciesRRMM, RRMDS
For Complete Detail Follow Below Link:
Complete Report @ http://www.reportsnreports.com/reports/274681-global-pharmaceutical-and-b
About ReportsnReports ReportsnReports.com is your single source for all market research needs. Our database includes 250,000+ syndicated market research reports from 100+ leading global publishers covering indepth analysis of over 5000 micro markets. With comprehensive information about the publishers and their report methodology, data sources, etc. we help you in your purchase decision by mapping your information needs with the most relevant available reports in our library.
Connect with us: sales@reportsandreports.com + 1 888 391 5441
Contact: sales@reportsandreports.com for further information. Contact: sales@reportsandreports.com for further information.